Treating Dry Eye at the Molecular Level
Update: 2024-10-08
Description
Jacob Lang, OD, FAAO, shares his knowledge of innovative therapies for dry eye with Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO. He discusses drugs in development that target pathways involved in ocular surface disease, such as reactive aldehyde species inhibitors, transient receptor potential receptors, and more.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
